DEVELOPMENT OF AN AUTOMATED PEPTIDE SYNTHESIZER

Information

  • Research Project
  • 2283976
  • ApplicationId
    2283976
  • Core Project Number
    R44RR008681
  • Full Project Number
    2R44RR008681-02A1
  • Serial Number
    8681
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1993 - 31 years ago
  • Project End Date
    8/31/1997 - 27 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1995 - 29 years ago
  • Budget End Date
    8/31/1996 - 28 years ago
  • Fiscal Year
    1995
  • Support Year
    2
  • Suffix
    A1
  • Award Notice Date
    8/29/1995 - 29 years ago
Organizations

DEVELOPMENT OF AN AUTOMATED PEPTIDE SYNTHESIZER

This proposal is directed towards the design, creation, and optimization of a fully automated peptide synthesis instrument capable of making over 100 peptides at a time using the broadly accepted FMOC chemistry in a parallel mode. This parallel approach will result in cycle times of less than 25 minutes for the simultaneous addition of 16 amino acids to up to 16 synthesis stacks each comprised of 1 to 8 synthesis wafers. Each wafer will produce up to a 20 micromole synthesis. Each peptide can be of completely independent sequence. Reagent consumption will be reduced by 50% over single synthesis instruments. Synthesis cost will be less than $2 per amino acid and enable the production of peptide libraries for applications requiring hundreds of peptides. Phase II will fully automate the Phase I synthesizer with an integral synthesis wafer sorter and the software to drive the operation of the machine and integrate it into a LIMS based peptide production facility. Another major goal is automation of post-synthesis processing to eliminate bottlenecks in the equally important phase of peptide production. Rapid and economical availability of hundreds of peptides will significantly accelerate research into biological activity screening, mutagenesis, structural studies, etc. PROPOSED COMMERCIAL APPLICATION: Final implementation of this technology will provide a machine for hundreds of peptide variations per day to enable studies of protein folding, site specific mutagenesis, hormone variant testing, antibody idiotype exploration, etc., while using considerably less reagents. The availability of multiple peptides empowers investigations that would take months just to synthesize the requisite peptides. All university core facilities, pharmaceutical companies and other large research institutions will benefit from the throughput of this synthesizer.

IC Name
NATIONAL CENTER FOR RESEARCH RESOURCES
  • Activity
    R44
  • Administering IC
    RR
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    371
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    SIGMA-GENOSYS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    THE WOODLANDS
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77380
  • Organization District
    UNITED STATES